Uptravi vs. Opsumit

Reviewed on 8/20/2020

Are Uptravi and Opsumit the Same Thing?

Uptravi (selexipag) and Opsumit (macitentan) are used to treat pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression.

Uptravi and Opsumit belong to different drug classes. Uptravi is a prostacyclin receptor agonist and Opsumit is an endothelin receptor antagonist.

Side effects of Uptravi and Opsumit that are similar include headache and low levels of iron in the blood (anemia).

Side effects of Uptravi that are different from Opsumit include diarrhea, jaw pain, nausea, muscle pain, vomiting, pain in extremities, flushing (warmth, redness, or tingly feeling), joint pain, decreased appetite, and rash.

Side effects of Opsumit that are different from Uptravi include common cold-like symptoms (stuffy nose or sore throat), bronchitis, flu, and urinary tract infection (UTI).

Both Uptravi and Opsumit may interact with rifampin.

Uptravi may also interact with gemfibrozil, teriflunomide, and deferasirox.

Opsumit may also interact with ketoconazole and ritonavir.

What Are Possible Side Effects of Uptravi?

Common side effects of Uptravi include:

Side effects of Uptravi include:

  • headache,
  • diarrhea,
  • jaw pain,
  • nausea,
  • muscle pain,
  • vomiting,
  • pain in extremities,
  • flushing (warmth, redness, or tingly feeling),
  • joint pain,
  • low levels of iron in the blood (anemia),
  • decreased appetite, or
  • rash

What Are Possible Side Effects of Opsumit?

Common side effects of Opsumit include:

QUESTION

COPD (chronic obstructive pulmonary disease) is the same as adult-onset asthma. See Answer

What Is Uptravi?

Uptravi (selexipag) is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression and reduce the risk of hospitalization for PAH.

What Is Opsumit?

Opsumit (macitentan) is an endothelin receptor antagonist used to treat pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression.

What Drugs Interact With Uptravi?

Uptravi may interact with strong inhibitors of CYP2C8 (e.g., gemfibrozil). Tell your doctor all medications and supplements you use.

What Drugs Interact With Opsumit?

Opsumit may interact with rifampin, ketoconazole, and ritonavir. Tell your doctor all medications and supplements you use. Opsumit is not recommended for use during pregnancy. It may harm a fetus.

How Should Uptravi be Taken?

The starting dose of Uptravi is 200 mcg twice daily. Increase the dose of Uptravi by 200 mcg twice daily at weekly intervals to the highest tolerated dose up to 1600 mcg twice daily.

How Should Opsumit be Taken?

The recommended dosage of Opsumit is 10 mg once daily for oral administration.

Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Actelion Pharmaceuticals Ltd. Uptravi Product Information.

www.uptravi.com/

Actelion Pharmaceuticals US, Inc. Opsumit Product Informtion

https://www.opsumit.com/

Health Solutions From Our Sponsors